EP3397756
IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
30.12.2016EP published:
8.3.2023EP application number:
16881286.5
EPO information:
European Patent Register
Max expiry date:
29.12.2036
Title in English:
IMMUNE EFFECTOR CELL THERAPIES WITH ENHANCED EFFICACYLanguage of the patent:
English
Timeline
Today
30.12.2016EP application
8.3.2023EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056 Basel, CH
Name:
The Trustees of The University of PennsylvaniaAddress:
3600 Civic Center Boulevard, 9th Floor, Philadelphia, PA 19104, US
Inventor
Name:
MOTZ, GregoryAddress:
Quincy Massachusetts 02170, US
Name:
MAVRAKIAS, Konstantinos JohnAddress:
Cambridge Massachusetts 02139, US
Name:
LIU, JinbiaoAddress:
Shanghai 201203, CN
Name:
LIU, LeiAddress:
Shanghai 201203, CN
Name:
ZHENG, QiangangAddress:
Shanghai 201318, CN
Name:
XUN, GuoliangAddress:
Shanghai 201203, CN
Name:
XIAO, QitaoAddress:
Shanghai 201203, CN
Priority
Number:
PCT/CN2015/099882Date:
30.12.2015Country:
WO
Classification
Categories:
C12N 5/0783, C12N 15/113, C07D 295/00, C07D 401/14, A61K 35/17, C07D 207/34, C07K 16/24, C07K 16/28, C07K 16/30, A61P 35/00